AtaiBeckley (ATAI) Proxy filing summary

Executive summary

• Entered into a definitive agreement for acquisition by Eli Lilly and Company, aiming to expand the global reach of mental health treatments.

• Transaction expected to deliver significant value to shareholders and employees.

• Announcement includes forward-looking statements regarding merger benefits, timeline, and integration plans.

Voting matters and shareholder proposals

• Shareholders will be asked to approve the agreement and plan of merger at a special meeting.

• Proxy statement and proxy card will be mailed to eligible stockholders for voting.

Board of directors and corporate governance

• Directors, executive officers, and certain employees may participate in the proxy solicitation.

• Information on director and executive officer stock ownership is available in recent SEC filings.